Search for: "State v. Tri-State Pharmaceutical"
Results 101 - 120
of 454
Sorted by Relevance
|
Sort by Date
9 Jun 2008, 8:33 pm
Aventis Pharma v. [read post]
21 Nov 2012, 5:00 am
The plaintiff in Miller, therefore, tried to distinguish the case from those involving oral-dose formulations, which really just take issue with inherent risks associated with the API. [read post]
7 Jun 2007, 10:52 am
Sandoz Pharmaceuticals Corp., 77 F. [read post]
7 May 2013, 8:24 am
Finally, plaintiffs tried to rely on Rule 4(k), which provides personal jurisdiction based on federal claims where the defendant may not be subject to jurisdiction in a particular state, but has minimum contacts with the U.S. as a whole. [read post]
29 May 2014, 5:00 am
That’s been tried before and failed − plaintiffs can’t avoid the statute by asserting claims against healthcare providers that purportedly sound in strict liability. [read post]
8 May 2012, 8:43 am
Then Rosetta Stone v. [read post]
31 Oct 2013, 9:00 am
Court of Appeals Decision; Stengel v. [read post]
22 Mar 2011, 9:15 am
Ortho Pharmaceutical Corp., 788 F.2d 741 (11th Cir. 1986). [read post]
22 Jan 2023, 8:19 am
Merrell Dow Pharmaceuticals. [read post]
19 May 2010, 10:48 am
Ortho-McNeil Pharma v. [read post]
12 Mar 2013, 6:20 am
Oct. 16, 2012) (following Guenther in denying similar request.Subsequently, another pair of A/Z plaintiffs tried again in Bowles v. [read post]
16 Apr 2008, 10:13 am
” (page 4, Riegel v. [read post]
9 Dec 2016, 7:03 am
A collocation attack is often tried, but is rarely successful. [read post]
24 Aug 2015, 5:00 am
Wyeth Pharmaceuticals, 797 F. [read post]
1 Mar 2013, 2:30 pm
All the while Maya v. [read post]
9 Dec 2013, 7:06 am
Saavedra v. [read post]
13 Jan 2014, 7:18 pm
Merrell Dow Pharmaceuticals, Inc. [read post]
7 Dec 2015, 5:30 am
In Maio v. [read post]
19 Apr 2011, 10:01 am
Novartis Pharmaceuticals, Inc., 06 Civ. 0260 (BMC) (RER), slip op. [read post]
6 Jan 2017, 6:28 am
United States v. [read post]
